Ultimate magazine theme for WordPress.

French health authority gives green light to Nuvaxovid vaccine – Paris News

“The data from various studies shows the high efficiency of the Nuvaxovid vaccine against the symptomatic forms of Covid-19 (nearly 90 per cent), and in particular against severe forms with nearly 100 per cent efficiency,” the authority mentioned in an announcement.

Nuvaxovid, manufactured by American biotechnology firm Novavax, is appropriate for folks over the age of 18, with a delay between doses of three weeks, it mentioned.

The health authority mentioned the Novaxovid vaccine can be utilized for individuals who haven’t acquired any pictures, or can’t obtain the mRNA vaccines.

The Ministry of Health has mentioned that the primary injections of Nuvaxovid can begin in February, and it’ll obtain 3.2 million doses for the primary trimester.

The first supply of vaccines will arrive on the finish of January.

The 5 Covid-19 vaccines authorised in France are Pfizer/BioNTech, Moderna, AstraZeneca, Janssen and Nuvaxovid.

Disclaimer: This story is auto-aggregated by a pc program and has not been created or edited by FreshersLIVE.Publisher : IANS-Media

Comments are closed.